A major new study published in the journal Clinical Gastroenterology and Hepatology has found that regular coffee consumption can substantially lower the risk of liver cancer and other severe liver diseases. Led by liver specialist Dr. Hyunseok Kim of Cedars-Sinai Medical Center in Los Angeles, researchers monitored more than 354,000 participants over a 10-year period to assess the long-term impacts of coffee on liver health. The findings revealed that individuals who drank up to five cups of coffee daily experienced a 47% reduction in the risk of developing liver cancer compared to non-coffee drinkers.

In addition to preventing malignancies, daily coffee consumption demonstrated widespread protective effects across other markers of advanced liver disease. The data showed that five daily cups of coffee were associated with a 32% lower risk of liver fibrosis (tissue scarring) and a 42% lower risk of death from overall liver disease. These improvements were physically verified using modern MRI scans, which consistently showed healthier, less scarred liver tissue among the regular coffee-drinking cohort.

Crucially, the study discovered that these positive health outcomes were not exclusive to caffeine. Participants who regularly consumed decaffeinated coffee experienced similar protective benefits, suggesting that caffeine is not the primary driver of these results. Instead, medical experts attribute the liver-shielding effects to the potent natural antioxidants present in coffee beans, which actively help reduce chronic inflammation and prevent harmful fat accumulation in the liver.